Cargando…
Patient benefit–risk in arthritis—a rheumatologist’s perspective
There is a range of pharmacological options available to the rheumatologist for treating arthritis. Non-selective NSAIDs or Cox-2 selective inhibitors are widely prescribed to reduce inflammation and alleviate pain; however, they must be used with caution in individuals with an increased cardiovascu...
Autor principal: | Bijlsma, Johannes W. J. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2857791/ https://www.ncbi.nlm.nih.gov/pubmed/20407136 http://dx.doi.org/10.1093/rheumatology/keq057 |
Ejemplares similares
-
Balancing gastrointestinal benefit–risk in individuals who are prescribed NSAIDs for arthritis
por: Bijlsma, Johannes W. J.
Publicado: (2010) -
The Psoriatic Arthritis Experience in Saudi Arabia from the Rheumatologist and Patient Perspectives
por: Alhomood, Ibrahim, et al.
Publicado: (2023) -
Rheumatologists’ perspective on hydroxychloroquine guidelines
por: Winebrake, James, et al.
Publicado: (2020) -
A Joint Consensus of Rheumatologists and Dermatologists on Early Detection and Effective Management of Psoriatic Arthritis: India's Perspective
por: Chatterjee, Manas, et al.
Publicado: (2022) -
Telemedicine and psoriatic arthritis: best practices and considerations for dermatologists and rheumatologists
por: Gottlieb, Alice B., et al.
Publicado: (2022)